Peripheral nerve stimulation for the management of acute and subacute post-amputation pain: a randomized, controlled feasibility trial.
Brooke Albright-TrainerThomas PhanRobert J TrainerNathan D CrosbyDouglas P MurphyPeter DisalvoMichael AmendolaDenise D LesterPublished in: Pain management (2021)
Introduction & aim: Temporary (60-day) percutaneous peripheral nerve stimulation (PNS) has demonstrated effectiveness for the treatment of chronic post-amputation pain, and this pilot study aims to evaluate the feasibility of temporary percutaneous PNS for the treatment of acute post-amputation pain. Patients & methods: Sixteen veterans undergoing lower extremity amputation received PNS and standard medical therapy or standard medical therapy alone. Results: The PNS group reported greater reductions in average phantom limb pain, residual limb pain and daily opioid consumption, and there were fewer participants taking opioids through 3 months post-amputation. Conclusion: This pilot study suggests that PNS is feasible in the acute postoperative period following lower limb amputation and may provide a non-pharmacologic analgesic therapy that lowers pain scores and reduces opioid consumption, and thus warrants further investigation.
Keyphrases
- chronic pain
- lower limb
- pain management
- neuropathic pain
- liver failure
- peripheral artery disease
- healthcare
- systematic review
- randomized controlled trial
- ejection fraction
- minimally invasive
- physical activity
- spinal cord
- spinal cord injury
- ultrasound guided
- chronic kidney disease
- bone marrow
- magnetic resonance
- aortic dissection
- replacement therapy
- cell therapy
- acute respiratory distress syndrome
- patient reported outcomes
- phase ii
- placebo controlled